Fundraising Fox

Codetta Bio

Morrisville, US · Founded 2021 · Delaware corporation · 2 known investors

Codetta Bio develops multiplex biomarker detection technology that combines digital PCR, real-time PCR, and immunoPCR with microbead-based target capture to simultaneously measure proteins, DNA, and RNA from a single sample. Its tools serve multi-omics research and life sciences applications.

Founders & leadership

Codetta Bio was founded in 2021 by Michael Ramsey.

MR
Michael RamseyCo-Founder
JCJacques Corriveau
Jacques CorriveauinExecutive
WHWilliam Hampton Henley
William Hampton HenleyExecutive
JM
J. Michael RamseyinNamed on SEC filing

Board

JH
John HoBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$12.3M disclosed across 1 round · 2024

$12.3MraisedOct 2024 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jacques CorriveauExecutive Officer, Director
  • William Hampton HenleyExecutive Officer
  • John HoDirector
  • J. Michael RamseyDirector
Offering amount
$26.4M
Amount sold
$12.3M
First sale
May 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 9

by search overlap
Concertobio5 shared keywordsConcerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.
bio4 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Synata Bio4 shared keywordsSynata Bio develops turnkey gas-fermentation technology that converts waste carbon and CO2 emissions from industrial processes into low-carbon ethanol and circular chemicals. It serves industrial customers seeking to decarbonize supply chains within the circular and hydrogen economies.
Taconic Biosciences4 shared keywordsTaconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services. It serves drug discovery and preclinical researchers, offering integrated laboratory animal models and services from model selection through study-ready cohorts.
Ditto Biosciences4 shared keywordsDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.
Octave3 shared keywordsOctave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. The company's tests enable physicians and patients to measure disease progression and treatment response through blood draws rather than traditional clinical assessments.
Tagbio3 shared keywordsTag.bio provides a data mesh platform for building and deploying governed data products in healthcare and life sciences. The platform enables secure data collaboration, AI model development, and multi-modal data integration for researchers, data scientists, and domain experts across biomedical organizations.
Predictabiosciences3 shared keywordsPredicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response. Its diagnostics serve clinicians, researchers, and pharmaceutical partners working in hematological malignancies such as multiple myeloma.
Vedanta Biosciences3 shared keywordsVedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection. Its oral therapies target gut dysbiosis-driven conditions.

Companies competing with Codetta Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Codetta Bio do?
Codetta Bio develops multiplex biomarker detection technology that combines digital PCR, real-time PCR, and immunoPCR with microbead-based target capture to simultaneously measure proteins, DNA, and RNA from a single sample. Its tools serve multi-omics research and life sciences applications.
Who founded Codetta Bio?
Codetta Bio was founded by Michael Ramsey in 2021.
Who are Codetta Bio's investors?
Codetta Bio's investors include Bantam Group, Genoa Ventures.
How much funding has Codetta Bio raised?
Codetta Bio has disclosed $12.3M raised across 1 round.
Where is Codetta Bio headquartered?
Codetta Bio is headquartered in Morrisville, US.